Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12608000537358
Ethics application status
Approved
Date submitted
26/09/2008
Date registered
24/10/2008
Date last updated
24/10/2008
Type of registration
Retrospectively registered
Titles & IDs
Public title
Metabolic effects of oestrogen compounds in men with low testosterone
Query!
Scientific title
Metabolic effects of SERMs (Selective Oestrogen Receptor Modulators) in hypogonadal men
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Metabolic effects in men with low testosterone
3758
0
Query!
Condition category
Condition code
Metabolic and Endocrine
3939
3939
0
0
Query!
Normal metabolism and endocrine development and function
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Raloxifene (120 mg) as 2 oral tablets a day for 6 months
Query!
Intervention code [1]
3472
0
Other interventions
Query!
Comparator / control treatment
placebo (sugar pill), 2 tablets a day for 6 month
Query!
Control group
Placebo
Query!
Outcomes
Primary outcome [1]
4836
0
Growth hormone (GH) secretion after arginine stimulation, measured by GH Elisa kit, Bioclone Australia
Query!
Assessment method [1]
4836
0
Query!
Timepoint [1]
4836
0
At baseline and after 1 and 6 months of treatment
Query!
Secondary outcome [1]
8161
0
Whole body protein turnover by leucine turnover technique.
Query!
Assessment method [1]
8161
0
Query!
Timepoint [1]
8161
0
At baseline and after 1 and 6 months of treatment
Query!
Secondary outcome [2]
8262
0
Fat and lean body mass by Dual energy xray absorptiometry (DEXA).
Query!
Assessment method [2]
8262
0
Query!
Timepoint [2]
8262
0
At baseline and after 1 and 6 months of treatment
Query!
Secondary outcome [3]
8263
0
Measurements of fat oxidation by indirect calorimetry
Query!
Assessment method [3]
8263
0
Query!
Timepoint [3]
8263
0
At baseline and after 1 and 6 months of treatment
Query!
Secondary outcome [4]
8264
0
Biochemical markers of growth hormone - insulin-like growth factor I (GH-IGFI) axis measured by radioimmuno assay.
Query!
Assessment method [4]
8264
0
Query!
Timepoint [4]
8264
0
At baseline and after 1 and 6 months of treatment
Query!
Eligibility
Key inclusion criteria
Hypogonadism (prostate cancer patients on androgen deprivation therapy for at least 6 months)
Query!
Minimum age
40
Years
Query!
Query!
Maximum age
80
Years
Query!
Query!
Sex
Males
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Androgen deprivation for less than 6 months, metastasis, cancer in other tissues than prostate, diabetes, kidney and liver disease, deep vein thrombosis
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 4
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Recruiting
Query!
Date of first participant enrolment
Anticipated
6/02/2008
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
24
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
Query!
Funding & Sponsors
Funding source category [1]
3935
0
Government body
Query!
Name [1]
3935
0
NHMRC (National Health & Medical Research Council)
Query!
Address [1]
3935
0
Level 5, 20 Allara Street Canberra ACT 2601
Query!
Country [1]
3935
0
Australia
Query!
Primary sponsor type
Hospital
Query!
Name
Department of Endocrinology, St Vincent's Hospital
Query!
Address
390 Victoria St Darlinghurst, NSW 2010
Query!
Country
Australia
Query!
Secondary sponsor category [1]
3527
0
None
Query!
Name [1]
3527
0
Query!
Address [1]
3527
0
Query!
Country [1]
3527
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
6000
0
St Vincents Hospital Human Research Ethics Committee
Query!
Ethics committee address [1]
6000
0
390 Victoria St Darlinghurst, NSW 2010
Query!
Ethics committee country [1]
6000
0
Australia
Query!
Date submitted for ethics approval [1]
6000
0
Query!
Approval date [1]
6000
0
05/10/2007
Query!
Ethics approval number [1]
6000
0
H07/070
Query!
Summary
Brief summary
We aim to investigate the effects of raloxifene (SERM) in hypogonadal men on the growth hormone system and metabolism.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
28982
0
Query!
Address
28982
0
Query!
Country
28982
0
Query!
Phone
28982
0
Query!
Fax
28982
0
Query!
Email
28982
0
Query!
Contact person for public queries
Name
12139
0
Prof Ken Ho, MD, FRACP, Head of Dept of Endocrinology, St Vincent’s Hospital
Query!
Address
12139
0
Pituitary Research Unit
Garvan Institute of Medical Research
384 Victoria Street
Darlinghurst
2010 NSW
Query!
Country
12139
0
Australia
Query!
Phone
12139
0
02 9295 8482
Query!
Fax
12139
0
02 9295 8481
Query!
Email
12139
0
[email protected]
Query!
Contact person for scientific queries
Name
3067
0
Prof Ken Ho, MD, FRACP, Head of Dept of Endocrinology, St Vincent’s Hospital
Query!
Address
3067
0
Pituitary Research Unit
Garvan Institute of Medical Research
384 Victoria Street
Darlinghurst
Query!
Country
3067
0
Australia
Query!
Phone
3067
0
02 9295 8482
Query!
Fax
3067
0
02 9295 8481
Query!
Email
3067
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF